找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Essentials of Non-Alcoholic Fatty Liver Disease; Complications and Ex Anca Trifan,Carol Stanciu,Cristina Muzica Book 2023 The Editor(s) (if

[復(fù)制鏈接]
樓主: Conformist
31#
發(fā)表于 2025-3-26 21:41:32 | 只看該作者
32#
發(fā)表于 2025-3-27 03:48:28 | 只看該作者
https://doi.org/10.1007/978-3-319-35083-7malignancies. Due to its frequent association with metabolic syndrome, NAFLD is considered a multisystemic disease, and it is a cause of many non-liver-related malignancies such as colorectal, esophageal, gastric, pancreatic, kidney, and breast cancer. The aim of this review is to summarize the extr
33#
發(fā)表于 2025-3-27 08:41:36 | 只看該作者
Corporate Social Responsibility global health burden worldwide. NAFLD includes the progressive disease spectrum from simple steatosis through nonalcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocarcinoma. Morbimortality is linked to the liver disease itself and to extrahepatic complications related to NAFLD and metab
34#
發(fā)表于 2025-3-27 11:21:26 | 只看該作者
35#
發(fā)表于 2025-3-27 14:24:57 | 只看該作者
36#
發(fā)表于 2025-3-27 18:30:43 | 只看該作者
http://image.papertrans.cn/e/image/315673.jpg
37#
發(fā)表于 2025-3-27 22:10:42 | 只看該作者
38#
發(fā)表于 2025-3-28 05:36:29 | 只看該作者
39#
發(fā)表于 2025-3-28 08:55:11 | 只看該作者
https://doi.org/10.1057/9780230801516prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.
40#
發(fā)表于 2025-3-28 13:46:40 | 只看該作者
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease,prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 05:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
桦南县| 乌什县| 芒康县| 华宁县| 腾冲县| 安吉县| 洛南县| 土默特左旗| 阿勒泰市| 罗甸县| 新竹市| 图木舒克市| 汕头市| 盐津县| 恩平市| 南陵县| 河津市| 玉屏| 黔西县| 米易县| 梧州市| 饶河县| 桃园市| 襄樊市| 黄骅市| 革吉县| 齐河县| 贡山| 伊川县| 定日县| 凤庆县| 随州市| 泸州市| 奇台县| 嘉善县| 民县| 常宁市| 洛川县| 云霄县| 襄樊市| 武城县|